Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Biotech
Gilead's Kite erodes $2.3B Shoreline cell therapy deal
The pact to pursue off-the-shelf CAR-NK therapies for blood cancers ended in the first quarter of this year, a Gilead spokesperson confirmed.
Darren Incorvaia
Sep 3, 2025 3:18pm
Novo seeks obesity refresh with $550M Replicate deal
Aug 28, 2025 7:00am
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Genentech scraps $2B cell therapy pact with Adaptive
Aug 18, 2025 2:40pm
Lilly crafts deal with UK biotech for new ALS antibodies
Jan 9, 2025 10:55am
Roche's Chugai inks Swiss ADC deal potentially worth over $780M
Jan 8, 2025 8:00am
